Terminated PHASE4 INTERVENTIONAL 2-arm NCT01486550

Hydroxyethyl Starch and Renal Function After Laparoscopic Nephrectomy (VONE)

Effect of Hydroxyethyl Starch on Renal Handling of Salt and Water, Blood Pressure-regulating Hormones, Proteins and Circulatory System of Patients Undergoing Kidney Removal by Keyhole Surgery

Sponsor: Regional Hospital Holstebro

Conditions Kidney Cancer

Interventions Sodium Chloride 9mg/ml Voluven (Hydroxyethyl starch 130/0,4)

Updated 5 times since 2017 Last updated: Oct 8, 2014 Started: Dec 31, 2011 Primary completion: Sep 30, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Lack of patient enrollment

Other Kidney Cancer trials with similar outcome

Browse all Kidney Cancer trials

Listed as NCT01486550, this PHASE4 trial focuses on Kidney Cancer and remains terminated or withdrawn. Sponsored by Regional Hospital Holstebro, it has been updated 5 times since 2011, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Dec 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Regional Hospital Holstebro

Data source: Regional Hospital Holstebro

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Holstebro, Denmark